Monday, June 17, 2024
HomeTagsCytoReason

CytoReason

CytoReason Collaborates with Merck KGaA, Darmstadt, Germany, on Cancer Immunotherapy Drug

CytoReason, an Israeli company developing computational disease models for more efficient drug discovery and development, today announced a collaboration with German multinational science and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics